• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Do sub-syndromal manic symptoms influence outcome in treatment resistant depression in adolescents? A latent class analysis from the TORDIA study.亚综合征躁狂症状是否会影响青少年治疗抵抗性抑郁症的预后?来自 TORDIA 研究的潜在类别分析。
J Affect Disord. 2012 Apr;138(1-2):86-95. doi: 10.1016/j.jad.2011.12.021. Epub 2012 Jan 30.
2
Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.青少年抑郁症经选择性 5-羟色胺再摄取抑制剂治疗初始抵抗后的长期结局:TORDIA 样本的随访研究。
J Clin Psychiatry. 2011 Mar;72(3):388-96. doi: 10.4088/JCP.09m05885blu.
3
Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression.快感缺失可预测接受选择性 5-羟色胺再摄取抑制剂治疗的青少年难治性抑郁症患者恢复较差。
J Am Acad Child Adolesc Psychiatry. 2012 Apr;51(4):404-11. doi: 10.1016/j.jaac.2012.01.011. Epub 2012 Mar 3.
4
Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial.鱼油单药治疗对双相情感障碍 I 高危青少年抑郁和前额叶神经化学的影响:一项为期 12 周的安慰剂对照质子磁共振波谱试验。
J Child Adolesc Psychopharmacol. 2020 Jun;30(5):293-305. doi: 10.1089/cap.2019.0124. Epub 2020 Mar 11.
5
Psychometric properties of the Children's Depression Rating Scale-Revised in adolescents.青少年版儿童抑郁评定量表修订版的心理测量特性。
J Child Adolesc Psychopharmacol. 2010 Dec;20(6):513-6. doi: 10.1089/cap.2010.0063.
6
A Characterization of the Clinical Global Impression Scale Thresholds in the Treatment of Adolescent Depression Across Multiple Rating Scales.多评估量表中青少年抑郁症治疗中临床总体印象量表阈值的特征描述。
J Child Adolesc Psychopharmacol. 2022 Jun;32(5):278-287. doi: 10.1089/cap.2021.0111.
7
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.对于患有对选择性5-羟色胺再摄取抑制剂(SSRI)耐药性抑郁症的青少年,换用另一种SSRI或联用或不联用认知行为疗法的文拉法辛治疗:TORDIA随机对照试验
JAMA. 2008 Feb 27;299(8):901-913. doi: 10.1001/jama.299.8.901.
8
Childhood depression subscales using repeated sessions on Children's Depression Rating Scale - revised (CDRS-R) scores.使用儿童抑郁评定量表修订版(CDRS-R)分数的重复测量来评估儿童抑郁症分量表。
J Child Adolesc Psychopharmacol. 2014 Aug;24(6):318-24. doi: 10.1089/cap.2013.0127.
9
Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression.睡眠障碍、易激惹与双相情感障碍儿童和青少年接受鲁拉西酮治疗的反应。
Curr Neuropharmacol. 2023;21(6):1393-1404. doi: 10.2174/1570159X20666220927112625.
10
Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.青少年难治性抑郁症治疗(TORDIA):第 24 周结果。
Am J Psychiatry. 2010 Jul;167(7):782-91. doi: 10.1176/appi.ajp.2010.09040552. Epub 2010 May 17.

引用本文的文献

1
Differences in Reward and Punishment Sensitivity among Adolescents with Depression Varying in Manic Symptoms.伴有不同躁狂症状的青少年抑郁症患者在奖惩敏感性上的差异
Res Child Adolesc Psychopathol. 2025 Jun 7. doi: 10.1007/s10802-025-01331-z.
2
Sex differences in pediatric major depressive episodes: a cross-sectional study on psychiatric symptoms in early-onset mood disorders.儿童重度抑郁发作中的性别差异:早发性情绪障碍精神症状的横断面研究
Front Psychiatry. 2025 Apr 25;16:1503794. doi: 10.3389/fpsyt.2025.1503794. eCollection 2025.
3
Major challenges in youth psychopathology: treatment-resistant depression. A narrative review.青少年精神病理学中的主要挑战:难治性抑郁症。一项叙述性综述。
Front Psychiatry. 2024 Jul 11;15:1417977. doi: 10.3389/fpsyt.2024.1417977. eCollection 2024.
4
Impact of different interventions on preventing suicide and suicide attempt among children and adolescents in the United States: a microsimulation model study.不同干预措施对预防美国儿童和青少年自杀及自杀未遂的影响:一项微观模拟模型研究
Front Psychiatry. 2023 Jun 2;14:1127852. doi: 10.3389/fpsyt.2023.1127852. eCollection 2023.
5
Trajectories of Symptom Change in School-Based Prevention Programs for Adolescent Girls with Subclinical Depression.基于学校的预防青少年亚临床抑郁女孩症状变化轨迹的研究。
J Youth Adolesc. 2022 Apr;51(4):659-672. doi: 10.1007/s10964-022-01578-5. Epub 2022 Feb 3.
6
Predictors, Moderators, and Mediators Associated With Treatment Outcome in Randomized Clinical Trials Among Adolescents With Depression: A Scoping Review.预测因素、调节因素和中介因素与抑郁症青少年随机临床试验治疗结果的关系:范围综述。
JAMA Netw Open. 2022 Feb 1;5(2):e2146331. doi: 10.1001/jamanetworkopen.2021.46331.
7
Latent Class Analysis of Adolescent Psychosocial Functioning and Course of Major Depression.青少年心理社会功能与重度抑郁症病程的潜在类别分析
Res Child Adolesc Psychopathol. 2021 Jul;49(7):963-973. doi: 10.1007/s10802-021-00791-3. Epub 2021 Feb 20.
8
Annual Research Review: Defining and treating pediatric treatment-resistant depression.年度研究综述:定义和治疗儿童难治性抑郁症。
J Child Psychol Psychiatry. 2020 Mar;61(3):312-332. doi: 10.1111/jcpp.13202. Epub 2020 Feb 4.
9
A systematic review of interventions for treatment resistant major depressive disorder in adolescents.系统评价青少年治疗抵抗性重度抑郁症的干预措施。
Eur Child Adolesc Psychiatry. 2020 Apr;29(4):433-443. doi: 10.1007/s00787-019-01341-5. Epub 2019 Jun 5.
10
Trajectories of Symptom Change in the Treatment for Adolescents With Depression Study.青少年抑郁症治疗研究中的症状变化轨迹。
J Am Acad Child Adolesc Psychiatry. 2019 Mar;58(3):319-328. doi: 10.1016/j.jaac.2018.07.908. Epub 2019 Jan 8.

本文引用的文献

1
Neurocognitive impairment in adolescent major depressive disorder: state vs. trait illness markers.青少年重度抑郁症的神经认知障碍:状态与特质疾病标志物。
J Affect Disord. 2011 Oct;133(3):625-32. doi: 10.1016/j.jad.2011.04.041. Epub 2011 May 26.
2
Relationship of persistent manic symptoms to the diagnosis of pediatric bipolar spectrum disorders.持续性躁狂症状与儿童双相谱系障碍诊断的关系。
J Clin Psychiatry. 2011 Jun;72(6):846-53. doi: 10.4088/JCP.10m06081yel. Epub 2011 Mar 22.
3
Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.青少年抑郁症经选择性 5-羟色胺再摄取抑制剂治疗初始抵抗后的长期结局:TORDIA 样本的随访研究。
J Clin Psychiatry. 2011 Mar;72(3):388-96. doi: 10.4088/JCP.09m05885blu.
4
Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study.具有躁狂症状升高特征的儿童:纵向评估躁狂症状(LAMS)研究。
J Clin Psychiatry. 2010 Dec;71(12):1664-72. doi: 10.4088/JCP.09m05859yel. Epub 2010 Oct 5.
5
Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication.在国家共病调查再研究中具有亚阈值双相性的重度抑郁障碍。
Am J Psychiatry. 2010 Oct;167(10):1194-201. doi: 10.1176/appi.ajp.2010.09071011. Epub 2010 Aug 16.
6
Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?未识别的双相情感障碍是否是导致明显治疗抵抗性抑郁症的常见原因?
J Affect Disord. 2010 Dec;127(1-3):10-8. doi: 10.1016/j.jad.2010.06.036. Epub 2010 Jul 23.
7
Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.青少年难治性抑郁症治疗(TORDIA):第 24 周结果。
Am J Psychiatry. 2010 Jul;167(7):782-91. doi: 10.1176/appi.ajp.2010.09040552. Epub 2010 May 17.
8
Risk factors of treatment resistance in major depression: association with bipolarity.重度抑郁症治疗抵抗的风险因素:与双相情感障碍的关联。
J Affect Disord. 2010 Oct;126(1-2):268-71. doi: 10.1016/j.jad.2010.03.001. Epub 2010 Apr 8.
9
Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression.静脉注射氯胺酮对难治性抑郁症患者自杀倾向的显性和隐性指标的影响。
Biol Psychiatry. 2009 Sep 1;66(5):522-6. doi: 10.1016/j.biopsych.2009.04.029. Epub 2009 Jul 9.
10
Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study.双相谱系障碍儿童和青少年的四年纵向病程:双相青少年的病程与转归(COBY)研究
Am J Psychiatry. 2009 Jul;166(7):795-804. doi: 10.1176/appi.ajp.2009.08101569. Epub 2009 May 15.

亚综合征躁狂症状是否会影响青少年治疗抵抗性抑郁症的预后?来自 TORDIA 研究的潜在类别分析。

Do sub-syndromal manic symptoms influence outcome in treatment resistant depression in adolescents? A latent class analysis from the TORDIA study.

机构信息

American University of Beirut, Lebanon.

出版信息

J Affect Disord. 2012 Apr;138(1-2):86-95. doi: 10.1016/j.jad.2011.12.021. Epub 2012 Jan 30.

DOI:10.1016/j.jad.2011.12.021
PMID:22284022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3621087/
Abstract

BACKGROUND

To identify distinct depressive symptom trajectories in the TORDIA study and determine their correlates.

METHODS

Latent Class Growth Analysis (LCGA) using the Children's Depression Rating Scale-Revised (CDRS-R) through 72 weeks from intake.

RESULTS

3 classes were identified: (1) little change in symptomatic status ("NO"), comprising 24.9% of participants, with a 72-week remission rate of 25.3%; (2) slow, steady improvement ("SLOW"), comprising 47.9% of participants, with a remission rate of 60.0%, and (3) rapid symptom response ("GO"), comprising 27.2% of participants, with a remission rate of 85.7%. Higher baseline CDRS-R (p<0.001) and poorer functioning (p=0.03) were the strongest discriminators between NO and GO. Higher baseline CDRS (p<0.001) and scores on the Mania Rating Scale (MRS) (p=0.01) were the strongest discriminators between SLOW and GO. Other variables differentiating GO from both NO and from SLOW, were better baseline functioning, lower hopelessness, and lower family conflict. Both NO and SLOW showed increases on the MRS over time compared to GO (ps ≤ 0.04), and increasing MRS was strongly associated with lack of remission by 72 weeks (p=0.02).

LIMITATIONS

High rate of open treatment by the end of the follow-up period creates difficulty in drawing clear inferences about the long-term impact of initial randomization.

CONCLUSION

Along with depressive severity, sub-syndromal manic symptoms, at baseline, and over time emerged as important predictors and correlates of poor outcome in this sample. Further research is needed on the treatment of severe depression, and on the assessment and management of sub-syndromal manic symptoms in treatment resistant depression.

摘要

背景

在 TORDIA 研究中确定不同的抑郁症状轨迹,并确定其相关性。

方法

使用儿童抑郁评定量表修订版(CDRS-R)通过 72 周的时间进行潜在类别增长分析(LCGA)。

结果

确定了 3 个类别:(1)症状状态无明显变化(“NO”),占参与者的 24.9%,72 周缓解率为 25.3%;(2)缓慢而稳定的改善(“SLOW”),占参与者的 47.9%,缓解率为 60.0%,以及(3)快速症状反应(“GO”),占参与者的 27.2%,缓解率为 85.7%。较高的基线 CDRS-R(p<0.001)和较差的功能(p=0.03)是区分 NO 和 GO 的最强指标。较高的基线 CDRS(p<0.001)和躁狂评定量表(MRS)评分(p=0.01)是区分 SLOW 和 GO 的最强指标。其他区分 GO 与 NO 和 SLOW 的变量是基线功能更好、绝望感更低以及家庭冲突更少。与 GO 相比,NO 和 SLOW 在整个研究过程中 MRS 均呈上升趋势(p≤0.04),并且 MRS 的增加与 72 周时未缓解强烈相关(p=0.02)。

局限性

随访结束时高比例的开放治疗增加了对初始随机分组长期影响的明确推断的难度。

结论

除了抑郁严重程度外,基线时和随时间推移出现的亚综合征躁狂症状也是该样本中预后不良的重要预测指标和相关性因素。需要进一步研究严重抑郁的治疗以及治疗抵抗性抑郁症中亚综合征躁狂症状的评估和管理。